Priority Date: 28.09.07 (US 20070995763P)

Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells

  • Application ID: EP13188706
  • Status: EXAMINATION IN PROGRESS

Applicant

Technology company logo small
Technology Company

Attorney

Employment test 1001 - 5000 employees
Company dna jones day
operating since 1893
1099.17
Headquarter in Cleveland and 38 offices
active in Legal Services

Specialization

This patent has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) Jones Day is specialized in A61. Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 28.09.2007 - Priority Date (US 20070995763P)
  • 01.10.2014 - Publication A1 (EP2783692)

IPC Classification